Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Incidence of Pulmonary Embolism During Nephrectomy
- Status
- COMPLETED
- Phase
- N/A
Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- NA
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
- Status
- RECRUITING
- Phase
- PHASE2
Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy
- Status
- COMPLETED
- Phase
- N/A
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
PET/MR Characterization of Renal Cell Carcinomas
- Status
- TERMINATED
- Phase
- NA
Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors
- Status
- UNKNOWN
- Phase
- N/A
Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Residual Normal Renal Parenchymal and Tumor Volume in Tumor Surgeries
- Status
- UNKNOWN
- Phase
- N/A
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.
- Status
- UNKNOWN
- Phase
- N/A
Laparoscopic Partial Nephrectomy for cT1 Tumors
- Status
- COMPLETED
- Phase
- N/A